Dr. Maria Rodebaugh, MD (she/her) is an Endocrinologist in Coeur d alene, ID with over 17 years of experience. What is your opinion of Dr. Maria Rodebaugh, MD? Rate this provider below so other people can make informed decision.
Over 17 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Maria Rodebaugh, MD has received over $7,215 which includes payments from the following companies:
$5,053.05 from Tandem Diabetes Care, Inc.
$294.92 from Novo Nordisk Inc
$276.60 from sanofi-aventis U.S. LLC
$242.91 from LILLY USA, LLC
$176.56 from Janssen Pharmaceuticals, Inc
$149.98 from INSULET CORPORATION
$134.63 from Medtronic MiniMed, Inc.
$114.53 from Novartis Pharmaceuticals Corporation
$110.48 from Dexcom, Inc.
$100.95 from Boehringer Ingelheim Pharmaceuticals, Inc.
$80.13 from AstraZeneca Pharmaceuticals LP
$74.70 from Shire North American Group Inc
$68.22 from Amgen Inc.
$46.27 from RECORDATI_RARE_DISEASES_INC.
$41.71 from Merck Sharp & Dohme Corporation
$39.62 from Antares Pharma, Inc.
$38.31 from Roche Diagnostics Corporation
$37.65 from GlaxoSmithKline, LLC.
$36.64 from AbbVie, Inc.
$25.32 from Roche Diabetes Care, Inc.
Payments received by Dr. Maria Rodebaugh, MD were from the following categories:
$4,900.00 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!